Skip to main content
Top
Published in: Translational Neurodegeneration 1/2016

Open Access 01-12-2016 | Research

A survey of impulse control disorders in Parkinson’s disease patients in Shanghai area and literature review

Authors: Xue-Ping Wang, Ming Wei, Qin Xiao

Published in: Translational Neurodegeneration | Issue 1/2016

Login to get access

Abstract

Background

Levodopa and dopamine agonists are the main treatments for Parkinson’s disease (PD) in recent years. Increased drug dosages are linked to some severe side effects, one of which is impulse control disorders (ICD). Many studies have reported the related risk factors of ICDs, such as dopamine agonist, male sex, younger age, earlier age of onset and so on. This study aims to investigate the incidence of ICD in Chinese PD patients from Shanghai area, explore the association of ICD with dopamine replacement therapy (DRT).

Methods

Two hundred seventeen PD patients were consecutively recruited from the Movement Disorder Clinic of Ruijin Hospital from March to October 2013. Minnesota Impulsive Disorders Interview was used to assess the PD patients. PD patients with possible ICD would undergo a further interview by a movement disorder specialist to confirm the diagnosis. Clinical information was also collected.

Results

Nine PD patients (4.15 %) showed ICD behaviors as follows: hypersexuality (4, 1.84 %), pathological gambling (3, 1.38 %), binge eating (1, 0.46 %), compulsive shopping (1, 0.46 %). Compared with the non-ICD PD group, ICD PD group took more dopamine agonists (LED 119.4 ± 86.4 mg/d vs 60.5 ± 80.5 mg/d, P = 0.019), had higher total levodopa equivalent dosage (TLED 912.81 ± 878.73 mg/d vs 503.78 ± 359.14 mg/d, P = 0.031), and had higher H&Y stage (2.33 ± 0.87 vs 1.41 ± 0.52, p = 0.013). However, logistic regression analysis didn’t reveal the above factors as independent risk factors of ICD behaviors in our study.

Conclusion

The incidence of ICDs behaviors in PD patients in our study is much lower than in western countries. ICD-PD group took higher dopamine agonists and higher total levodopa equivalent dosage, even though logistic regression analysis didn’t reveal them as independent risk factors.
Literature
1.
go back to reference Hoehn MM. The natural history of Parkinson's disease in the pre-levodopa and post-levodopa eras. Neurol Clin. 1992;10(2):331–9.PubMed Hoehn MM. The natural history of Parkinson's disease in the pre-levodopa and post-levodopa eras. Neurol Clin. 1992;10(2):331–9.PubMed
2.
go back to reference Fahn S. The spectrum of levodopa-induced dyskinesias. Ann Neurol. 2000;47(4 Suppl 1):S2-9; discussion S9-11. Fahn S. The spectrum of levodopa-induced dyskinesias. Ann Neurol. 2000;47(4 Suppl 1):S2-9; discussion S9-11.
3.
go back to reference Lim SY, Evans AH, Miyasaki JM. Impulse control and related disorders in Parkinson's disease: review. Ann N Y Acad Sci. 2008;1142:85–107.CrossRefPubMed Lim SY, Evans AH, Miyasaki JM. Impulse control and related disorders in Parkinson's disease: review. Ann N Y Acad Sci. 2008;1142:85–107.CrossRefPubMed
4.
go back to reference Chiang HL et al. Are there ethnic differences in impulsive/compulsive behaviors in Parkinson's disease? Eur J Neurol. 2012;19(3):494–500.CrossRefPubMed Chiang HL et al. Are there ethnic differences in impulsive/compulsive behaviors in Parkinson's disease? Eur J Neurol. 2012;19(3):494–500.CrossRefPubMed
5.
go back to reference Valenca GT et al. Past smoking and current dopamine agonist use show an independent and dose-dependent association with impulse control disorders in Parkinson's disease. Parkinsonism Relat Disord. 2013;19(7):698–700.CrossRefPubMed Valenca GT et al. Past smoking and current dopamine agonist use show an independent and dose-dependent association with impulse control disorders in Parkinson's disease. Parkinsonism Relat Disord. 2013;19(7):698–700.CrossRefPubMed
6.
go back to reference Weintraub D et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol. 2010;67(5):589–95.CrossRefPubMed Weintraub D et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol. 2010;67(5):589–95.CrossRefPubMed
7.
go back to reference Joutsa J et al. Impulse control disorders and depression in Finnish patients with Parkinson's disease. Parkinsonism Relat Disord. 2012;18(2):155–60.CrossRefPubMed Joutsa J et al. Impulse control disorders and depression in Finnish patients with Parkinson's disease. Parkinsonism Relat Disord. 2012;18(2):155–60.CrossRefPubMed
8.
go back to reference Poletti M et al. A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs. J Clin Psychopharmacol. 2013;33(5):691–4.CrossRefPubMed Poletti M et al. A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs. J Clin Psychopharmacol. 2013;33(5):691–4.CrossRefPubMed
9.
go back to reference Tanaka K et al. Impulsive compulsive behaviors in Japanese Parkinson's disease patients and utility of the Japanese version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's disease. J Neurol Sci. 2013;331(1–2):76–80.CrossRefPubMed Tanaka K et al. Impulsive compulsive behaviors in Japanese Parkinson's disease patients and utility of the Japanese version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's disease. J Neurol Sci. 2013;331(1–2):76–80.CrossRefPubMed
10.
go back to reference Fan W et al. Impulse control disorders in Parkinson's disease in a Chinese population. Neurosci Lett. 2009;465(1):6–9.CrossRefPubMed Fan W et al. Impulse control disorders in Parkinson's disease in a Chinese population. Neurosci Lett. 2009;465(1):6–9.CrossRefPubMed
11.
go back to reference Lee JY et al. Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease. Parkinsonism Relat Disord. 2010;16(3):202–7.CrossRefPubMed Lee JY et al. Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease. Parkinsonism Relat Disord. 2010;16(3):202–7.CrossRefPubMed
12.
go back to reference Lim SY et al. Impulsive-compulsive behaviors are common in Asian Parkinson's disease patients: assessment using the QUIP. Parkinsonism Relat Disord. 2011;17(10):761–4.CrossRefPubMed Lim SY et al. Impulsive-compulsive behaviors are common in Asian Parkinson's disease patients: assessment using the QUIP. Parkinsonism Relat Disord. 2011;17(10):761–4.CrossRefPubMed
13.
go back to reference Voon V, Fox SH. Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol. 2007;64(8):1089–96.CrossRefPubMed Voon V, Fox SH. Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol. 2007;64(8):1089–96.CrossRefPubMed
14.
go back to reference Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988;51(6):745–52.PubMedCentralCrossRefPubMed Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988;51(6):745–52.PubMedCentralCrossRefPubMed
15.
go back to reference Lee JY et al. Genetic variant of HTR2A associates with risk of impulse control and repetitive behaviors in Parkinson's disease. Parkinsonism Relat Disord. 2012;18(1):76–8.CrossRefPubMed Lee JY et al. Genetic variant of HTR2A associates with risk of impulse control and repetitive behaviors in Parkinson's disease. Parkinsonism Relat Disord. 2012;18(1):76–8.CrossRefPubMed
16.
go back to reference Blum K et al. Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour. Pharmacogenetics. 1995;5(3):121–41.CrossRefPubMed Blum K et al. Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour. Pharmacogenetics. 1995;5(3):121–41.CrossRefPubMed
17.
go back to reference Lee JY et al. Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease. Mov Disord. 2009;24(12):1803–10.CrossRefPubMed Lee JY et al. Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease. Mov Disord. 2009;24(12):1803–10.CrossRefPubMed
18.
19.
go back to reference Klos KJ et al. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord. 2005;11(6):381–6.CrossRefPubMed Klos KJ et al. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord. 2005;11(6):381–6.CrossRefPubMed
20.
go back to reference Galpern WR, Stacy M. Management of impulse control disorders in Parkinson's disease. Curr Treat Options Neurol. 2007;9(3):189–97.CrossRefPubMed Galpern WR, Stacy M. Management of impulse control disorders in Parkinson's disease. Curr Treat Options Neurol. 2007;9(3):189–97.CrossRefPubMed
21.
go back to reference Uitti RJ et al. Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol. 1989;12(5):375–83.CrossRefPubMed Uitti RJ et al. Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol. 1989;12(5):375–83.CrossRefPubMed
22.
23.
go back to reference Sohtaoglu M et al. Long term follow-up of Parkinson's disease patients with impulse control disorders. Parkinsonism Relat Disord. 2010;16(5):334–7.CrossRefPubMed Sohtaoglu M et al. Long term follow-up of Parkinson's disease patients with impulse control disorders. Parkinsonism Relat Disord. 2010;16(5):334–7.CrossRefPubMed
24.
go back to reference Tomlinson CL et al. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord. 2010;25(15):2649–53.CrossRefPubMed Tomlinson CL et al. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord. 2010;25(15):2649–53.CrossRefPubMed
Metadata
Title
A survey of impulse control disorders in Parkinson’s disease patients in Shanghai area and literature review
Authors
Xue-Ping Wang
Ming Wei
Qin Xiao
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Translational Neurodegeneration / Issue 1/2016
Electronic ISSN: 2047-9158
DOI
https://doi.org/10.1186/s40035-016-0051-7

Other articles of this Issue 1/2016

Translational Neurodegeneration 1/2016 Go to the issue